← back to search

Yu Wang

Chinese Academy of Sciences · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Circular RNAs in diseases, MicroRNA in disease regulation, Cancer-related molecular mechanisms research, and Ferroptosis and cancer prognosis.
h-index
33
citations
4,286
works
182
NIH funding
primary concept
email

Recent publications

A Pan-Inhibitor of Phosphate Transporters AP306 in Hemodialysis Patients
Kidney International Reports 2025cited by 5position: middledoi
Prevalence and predictive importance for short-term clinical outcomes of GLIM-defined malnutrition among adult inpatients: A nationwide cross-sectional study
Clinical Nutrition 2025cited by 3position: middledoi
Hsa_circ_0001304 promotes vascular neointimal hyperplasia accompanied by autophagy activation
Communications Biology 2025cited by 3position: middledoi
The Multitarget Compound ZLY032 Achieves Treatment of Chronic Wounds
Advanced Science 2025cited by 2position: middledoi
Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance
Nature Cancer 2024cited by 53position: middledoi
Construction of ceRNA network mediated by circRNAs screening from microarray and identification of novel biomarkers for myasthenia gravis
Gene 2024cited by 4position: middledoi
Hsa_circ_0001304 promotes vascular smooth muscle cell autophagy and neointimal hyperplasia through the YTHDF2/mTOR axis
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 0position: middledoi
Integrated analysis of the lncRNA-associated ceRNA network in Alzheimer's disease
Gene 2023cited by 9position: middledoi
Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer
EBioMedicine 2022cited by 55position: middledoi
The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer
Frontiers in Endocrinology 2022cited by 25position: firstdoi
Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response
Cell Discovery 2021cited by 300position: firstdoi
Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer
Signal Transduction and Targeted Therapy 2021cited by 260position: middledoi
Transcriptomic analysis reveals essential microRNAs after peripheral nerve injury
Neural Regeneration Research 2021cited by 18position: middledoi
Comparative analysis of circRNA expression profile and circRNA-miRNA-mRNA regulatory network between palmitic and stearic acid-induced lipotoxicity to pancreatic β cells
Bioengineered 2021cited by 8position: middledoi
Additional file 2 of Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin
Figshare 2021cited by 0position: middledoi
Inhibition of mTORC1 by lncRNA H19 via disrupting 4E-BP1/Raptor interaction in pituitary tumours
Nature Communications 2018cited by 140position: middledoi
Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition
Oncotarget 2017cited by 26position: middledoi
Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence
Thyroid 2016cited by 89position: middledoi
Low expression of Bin1, along with high expression of IDO in tumor tissue and draining lymph nodes, are predictors of poor prognosis for esophageal squamous cell cancer patients
International Journal of Cancer 2015cited by 98position: middledoi
HOTAIR is a potential target for the treatment of cisplatin-resistant ovarian cancer
Molecular Medicine Reports 2015cited by 57position: firstdoi
The chemokine receptor‐<scp>CXCR</scp>2 plays a critical role in the invasion and metastases of oral squamous cell carcinoma <i>in vitro</i> and <i>in vivo</i>
Journal of Oral Pathology and Medicine 2014cited by 19position: middledoi
Basigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancer
Journal of Translational Medicine 2013cited by 25position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yuqing Duan · Xi'an Medical University3 papers (2015–2021)Meng Li · Guangxi Medical University2 papers (2024–2025)Li Yang · Hebei Medical University2 papers (2024–2025)Ming Ma · Hebei Medical University2 papers (2015–2017)Yuguang Cao · China University of Petroleum, Beijing2 papers (2024–2025)Zhaoyi Wang · Jinggangshan University2 papers (2024–2025)Zi-Qi Dong · Hebei Medical University2 papers (2024–2025)Wei Lv · State Key Laboratory of Polymer Physics and Chemistry2 papers (2017–2021)Yunlong Jia · University of California, Irvine2 papers (2015–2017)Sen Wang · Northwest Institute of Nuclear Technology2 papers (2024–2025)Shiqing Mu · Hebei Medical University2 papers (2024–2025)Sifan Wang · Hebei Medical University2 papers (2024–2025)Liyun Yang · Hebei Medical University2 papers (2024–2025)Xuexiao Wang · Hebei Medical University2 papers (2017–2021)Ze-An Jiang · Hebei Medical University2 papers (2024–2025)Jiajie Lin · Sun Yat-sen University2 papers (2024–2025)Shan‐Hu Cao · Hebei Medical University2 papers (2024–2025)Shao-Guang Sun · Hebei Medical University2 papers (2024–2025)Anqi Zhao · Shanxi Provincial Cancer Hospital2 papers (2024–2025)Shuyan Yang · Hebei Medical University2 papers (2024–2025)